Fungal infections as a complication of therapy for sarcoidosis

QJM: An International Journal of Medicine

Volumn 98, Issue 6, 2005, Pages 451-456

  Baughman, R P ^a,b   Lower, E E ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUCONAZOLE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLIXIMAB; ITRACONAZOLE; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; THALIDOMIDE; VORICONAZOLE;

ASPERGILLOSIS; BLASTOMYCES DERMATITIDIS; BONE MARROW BIOPSY; BRONCHOSCOPY; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRYPTOCOCCUS NEOFORMANS; DRUG DOSE REDUCTION; DRUG RESPONSE; HISTOPLASMA CAPSULATUM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MYCOSIS; OPEN LUNG BIOPSY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SARCOIDOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

EID: 20444430052     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hci073     Document Type: Review

References (33)

1. Siltzbach LE. Effects of cortisone in sarcoidosis: a study of thirteen patients. Am J Med 1952; 12:139-60.
2. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 2002; 287:1301-7.
3. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-73.
4. Baughman RP, du Bois RM, Lower EE. Sarcoidosis. Lancet 2003; 361:1111-18.
5. Baughman RP. The lung in the immunocompromised patient: infectious complications Part 1. Respiration 1999; 66:95-109.
6. Sadikot RT, Dore P, Arnold AG. Sarcoidosis and opportunistic infections. South Med J 2001; 94:75-7.
7. Abarquez CA, Sharma OP. Histoplasmoma in a patient with sarcoidosis. Sarcoidosis 1991; 8:69-71.
8. Yaseen Z, Havlichek D, Mathes B, Hahn MH. Disseminated histoplasmosis in a patient with sarcoidosis: a controversial relationship and a diagnostic dilemma. Am J Med Sci 1997; 313:187-90.
9. Winterbauer RH, Kraemer KG. The infectious complications of sarcoidosis: a current perspective. Arch Intern Med 1976; 136:1356-62.
10. Griep EN, van Spiegel PI, van Soesbergen RM. Sarcoidosis accompanied by pulmonary tuberculosis and complicated by sacroiliitis. Arthritis Rheum 1993; 36:716-21.
11. Botha RJ, Wessels E. Cryptococcal meningitis in an HIV negative patient with systemic sarcoidosis. J Clin Pathol 1999; 52:928-30.
12. Shijubo N, Fujishima T, Ooashi K, et al. Pulmonary cryptococcal infection in an untreated patient with sarcoidosis. Sarcoidosis 1995; 12:71-4.
13. Nottebart HC, McGehee RF, Utz JP. Cryptococcosis complicating sarcoidosis. Am Rev Respir Dis 1973; 107:1060-3.
14. Wheat LJ, French ML, Wass JL. Sarcoidlike manifestations of histoplasmosis. Arch Intern Med 1989; 149:2421-6.
15. Bretza J, Mayfield JD. Mycobacterium intracellulare presenting as a sarcoid-like illness. South Med J 1978; 71:872-4.
16. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111:623-31.
17. Baughman RP, Dohn MN, Loudon RG, Frame PT. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest 1991; 99:92-7.
18. Baughman RP, Dohn MN, Frame PT. The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients. Am J Med 1994; 97:515-22.
19. Sternberg RI, Baughman RP, Dohn MN, First MR. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med 1993; 95:358-64.
20. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155:846-51.
21. Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurologic involvement. Arch Neurol 1998; 55:1248-54.
22. Muller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 1999; 14:1117-22.
23. Baughman RP, Lower EE. Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21:43-8.
24. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurologic sarcoidosis. Arch Intern Med 1997; 157:1864-68.
25. Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Thalidomide for chronic sarcoidosis. Chest 2002; 122:227-32.
26. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18:70-4.
27. Baughman RP, Lower EE. Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis 1997; 14:121-30.
28. Allen KS, Glickstein M, Arger PH, Bilaniuk L, Levy DW. Cryptococcosis associated with sarcoidosis: CT and MR findings. J Comput Assist Tomogr 1988; 12:420-2.
29. Giner V, Casademont J, Cardellach F. Cryptococcal meningoencephalitis and sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:229-30.
30. Ross JJ, Katz JD. Cryptococcal meningitis and sarcoidosis. Scand J Infect Dis 2002; 34:937-9.
31. Belcher RW, Palazij R, Wolinsky E. Immunologic studies in patients with sarcoidosis and cryptococcosis. Arch Dermatol 1975; 111:711-16.
32. Tomlinson JR, Sahn SA. Aspergilloma in sarcoid and tuberculosis. Chest 1987; 92:505-8.
33. De Beule K, De Doncker P, Cauwenbergh G, et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 1988; 31:476-85.